Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global G-Protein Coupled Receptors (GPCRs) Market, By Product
7.1. G-Protein Coupled Receptors (GPCRs) Market, By Product, 2021-2028
7.1.1. Cell Lines
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Detection Kits
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Cell Culture Reagents
7.1.3.1. Market Revenue and Forecast (2016-2028)
7.1.4. Ligands
7.1.4.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global G-Protein Coupled Receptors (GPCRs) Market, By Application
8.1. G-Protein Coupled Receptors (GPCRs) Market, by Application, 2021-2028
8.1.1. Cancer Research
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. CNS Research
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Metabolic Research
8.1.3.1. Market Revenue and Forecast (2016-2028)
8.1.4. Cardiovascular Research
8.1.4.1. Market Revenue and Forecast (2016-2028)
8.1.5. Respiratory Research
8.1.5.1. Market Revenue and Forecast (2016-2028)
8.1.6. Inflammation Research
8.1.6.1. Market Revenue and Forecast (2016-2028)
8.1.7. Other Application
8.1.7.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global G-Protein Coupled Receptors (GPCRs) Market, Assay Type
9.1. G-Protein Coupled Receptors (GPCRs) Market, Assay Type, 2021-2028
9.1.1. cAMP Functional Assays
9.1.1.1. Market Revenue and Forecast (2016-2028)
9.1.2. Calcium Functional Assays
9.1.2.1. Market Revenue and Forecast (2016-2028)
9.1.3. β-Arrestin Functional Assays
9.1.3.1. Market Revenue and Forecast (2016-2028)
9.1.4. Radioligand Binding and GTPγS Functional Assays
9.1.4.1. Market Revenue and Forecast (2016-2028)
9.1.5. Internalization Assays
9.1.5.1. Market Revenue and Forecast (2016-2028)
9.1.6. Trafficking Assays
9.1.6.1. Market Revenue and Forecast (2016-2028)
9.1.7. Other Assays
9.1.7.1. Market Revenue and Forecast (2016-2028)
Chapter 10. Global G-Protein Coupled Receptors (GPCRs) Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Product (2016-2028)
10.1.2. Market Revenue and Forecast, by Application (2016-2028)
10.1.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.1.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.1.4.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.1.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.1.5.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Product (2016-2028)
10.2.2. Market Revenue and Forecast, by Application (2016-2028)
10.2.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.2.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.2.4.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.2.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.2.5.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Product (2016-2028)
10.2.6.2. Market Revenue and Forecast, by Application (2016-2028)
10.2.6.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Product (2016-2028)
10.2.7.2. Market Revenue and Forecast, by Application (2016-2028)
10.2.7.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Product (2016-2028)
10.3.2. Market Revenue and Forecast, by Application (2016-2028)
10.3.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.3.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.3.4.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.3.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.3.5.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Product (2016-2028)
10.3.6.2. Market Revenue and Forecast, by Application (2016-2028)
10.3.6.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Product (2016-2028)
10.3.7.2. Market Revenue and Forecast, by Application (2016-2028)
10.3.7.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.4.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.4.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.4.4.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.4.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.4.5.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Product (2016-2028)
10.4.6.2. Market Revenue and Forecast, by Application (2016-2028)
10.4.6.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Product (2016-2028)
10.4.7.2. Market Revenue and Forecast, by Application (2016-2028)
10.4.7.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.5.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Product (2016-2028)
10.5.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.5.4.3. Market Revenue and Forecast, Assay Type (2016-2028)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Product (2016-2028)
10.5.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.5.5.3. Market Revenue and Forecast, Assay Type (2016-2028)
Chapter 11. Company Profiles
11.1. GPCRs market include Thermo Fisher Scientific, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Eurofins Scientific
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. QIAGEN
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. WuXi AppTec(HD Biosciences Co. Ltd)
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Promega Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Abcam plc
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Perkin Elmer Inc.(Cisbio Bioassays)
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Enzo Biochem Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Merck KGaA
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Becton-Dickinson and Company
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms